Literature DB >> 31157256

Ability of serum procalcitonin to distinguish focus of infection and pathogen types in patients with bloodstream infection.

Yinzhi Leng1,2, Caiyun Chen3, Yongxiang Zhang2, Can Luo3, Bo Liu2.   

Abstract

BACKGROUND: Serum procalcitonin (PCT) is a widely recognized inflammatory marker which can distinguish systemic bacterial infection from other types of infections. The ability of PCT levels to distinguish different pathogens from different focus of infection is contradictory.
METHODS: This study included 551 patients with bloodstream infection (BSI) diagnosed with positive blood culture (BC) during Jan 2013 and May 2018. The patients were divided into two groups with or without definite focus of infection. In this study, we analyzed PCT levels induced by Gram-positive bacteria, Gram-negative bacteria and fungal infection. Relationship of time between PCT peak and BC collection, and the impact of antibiotics usage on PCT peak distribution were examined.
RESULTS: For patients without definite focus of infection, the serum PCT values of Gram-negative bacteria were higher than that of Gram-positive bacteria (P<0.05). A cut-off value of 7.54 ng/mL for PCT showed a sensitivity of 88.3%. For patients with definite focus of infection, the serum PCT values of Gram-negative bacteria were significantly higher than Gram-positive bacteria in patients with lower respiratory tract (P=0.003), abdominal (P=0.039), urinary tract infection (P=0.025), but not in patients with upper respiratory tract infection (P=0.664). The PCT values between multidrug-resistant organism (MDRO) and sensitive bacteria were not statistically significant (P>0.05) among all patients. Moreover, among patients who use antibiotics before BC collection, the longer antibiotics used, the higher trend of the proportion for PCT peak distribution after BC collection. The higher proportion of antibiotics combined before BC collection, the lower proportion of PCT peak distribution appeared before BC collection, and the higher the proportion of PCT peak distribution appeared after BC collection.
CONCLUSIONS: PCT value is determined by many factors. PCT value is related to not only Gram-positive bacteria or Gram-negative bacteria, but also related to specific pathogens, and specific of infection sites etc. The use of Antibiotics is also an important factor of PCT value.

Entities:  

Keywords:  Procalcitonin; antibiotics use; bloodstream infection (BSI); multidrug-resistant organism (MDRO); pathogen

Year:  2019        PMID: 31157256      PMCID: PMC6511569          DOI: 10.21037/atm.2019.03.24

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  33 in total

Review 1.  Immune regulation of procalcitonin: a biomarker and mediator of infection.

Authors:  G N Matwiyoff; J D Prahl; R J Miller; J J Carmichael; D E Amundson; G Seda; M Daheshia
Journal:  Inflamm Res       Date:  2012-02-22       Impact factor: 4.575

Review 2.  Management of multidrug-resistant organisms in health care settings, 2006.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

Review 3.  Procalcitonin in bacterial infections--hype, hope, more or less?

Authors:  Mirjam Christ-Crain; Beat Müller
Journal:  Swiss Med Wkly       Date:  2005-08-06       Impact factor: 2.193

4.  Production of procalcitonin (PCT) in non-thyroidal tissue after LPS injection.

Authors:  N G Morgenthaler; J Struck; Y Chancerelle; W Weglöhner; D Agay; C Bohuon; V Suarez-Domenech; A Bergmann; B Müller
Journal:  Horm Metab Res       Date:  2003-05       Impact factor: 2.936

5.  Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma.

Authors:  Gian Paolo Castelli; Claudio Pognani; Massimo Cita; Rolando Paladini
Journal:  Crit Care Med       Date:  2009-06       Impact factor: 7.598

Review 6.  Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis.

Authors:  Liliana Simon; France Gauvin; Devendra K Amre; Patrick Saint-Louis; Jacques Lacroix
Journal:  Clin Infect Dis       Date:  2004-07-02       Impact factor: 9.079

7.  Differential immunostimulatory effects of Gram-positive bacteria due to their lipoteichoic acids.

Authors:  Young Hee Ryu; Jung Eun Baik; Jae Seung Yang; Seok-Seong Kang; Jintaek Im; Cheol-Heui Yun; Dong Wook Kim; Kangseok Lee; Dae Kyun Chung; Hyang Ran Ju; Seung Hyun Han
Journal:  Int Immunopharmacol       Date:  2008-11-14       Impact factor: 4.932

8.  Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality.

Authors:  John R Prowle; Jorge E Echeverri; E Valentina Ligabo; Norelle Sherry; Gopal C Taori; Timothy M Crozier; Graeme K Hart; Tony M Korman; Barrie C Mayall; Paul D R Johnson; Rinaldo Bellomo
Journal:  Crit Care       Date:  2011-03-21       Impact factor: 9.097

Review 9.  Global spread of Carbapenemase-producing Enterobacteriaceae.

Authors:  Patrice Nordmann; Thierry Naas; Laurent Poirel
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883

Review 10.  Bench-to-bedside review: sepsis, severe sepsis and septic shock - does the nature of the infecting organism matter?

Authors:  Hongmei Gao; Timothy W Evans; Simon J Finney
Journal:  Crit Care       Date:  2008-05-06       Impact factor: 9.097

View more
  5 in total

1.  Low Levels of Procalcitonin Are Related to Decreased Antibiotic Use in Children Hospitalized Due to Influenza.

Authors:  August Wrotek; Oliwia Wrotek; Teresa Jackowska
Journal:  Diagnostics (Basel)       Date:  2022-05-05

2.  Portal vein thrombosis secondary to postoperative gastric cancer: Report of two cases.

Authors:  Zhen Zhang; Yan Mei; Haidong Cheng; Xinlin Wu
Journal:  J Int Med Res       Date:  2019-12-16       Impact factor: 1.671

3.  Performance verification of a new domestic chemiluminescence detection system.

Authors:  Lihua Yang; Lin Wang; Yuji Gong; Wenpu Shi; Xiaohu An; Huifei Zheng
Journal:  Ann Transl Med       Date:  2020-11

4.  Diagnostic Value and Prognostic Significance of Procalcitonin Combined with C-Reactive Protein in Patients with Bacterial Bloodstream Infection.

Authors:  Yan Zhang; Mei La; Jihong Sun; Mimi Chen; Dandan Liu; Xiaolin Liu; Yating Kang
Journal:  Comput Math Methods Med       Date:  2022-08-11       Impact factor: 2.809

5.  Association of Procalcitonin with the Patient's Infection Characteristics and Prognosis after Hematopoietic Stem Cell Transplantation.

Authors:  Shan-Shan Li; Jun-Xu Gu; Xiao-Wei Li; Na Zhang; Mei Jia; Lin Pei; Ming Su
Journal:  Dis Markers       Date:  2022-09-13       Impact factor: 3.464

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.